Provided by Tiger Trade Technology Pte. Ltd.

Longeveron Inc

7.33
+0.690010.39%
Post-market: 7.340.0100+0.14%16:11 EDT
Volume:66.69K
Turnover:473.18K
Market Cap:23.16M
PE:-0.73
High:7.36
Open:6.79
Low:6.64
Close:6.64
52wk High:12.30
52wk Low:4.75
Shares:3.16M
Float Shares:2.73M
Volume Ratio:1.49
T/O Rate:2.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0000
EPS(LYR):-12.9172
ROE:-203.61%
ROA:-90.95%
PB:2.23
PE(LYR):-0.57

Loading ...

Longeveron says new Phase 2a analysis of laromestrocel in mild Alzheimer’s accepted for AAIC 2026 poster presentation

Reuters
·
Jun 18

Longeveron wins EMA small, medium-sized enterprise status

Reuters
·
Jun 09

Longeveron Granted Small or Medium-Sized Enterprise (SME) Status by the European Medicines Agency (Ema)

THOMSON REUTERS
·
Jun 09

Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)

GlobeNewswire
·
Jun 09

Longeveron Announces CFO Transition to Internal Successor

TIPRANKS
·
Jun 06

BRIEF-Longeveron - On June 1, Lisa Locklear To Step Down As CFO Effective July 10, 2026 - SEC Filing

Reuters
·
Jun 06

Longeveron - on June 1, Lisa Locklear to Step Down as CFO Effective July 10, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 06

Longeveron - Anticipates Marie Washburn to Be Elevated to CFO Pending Final Contract - SEC Filing

THOMSON REUTERS
·
Jun 06

Longeveron to present at BIO International Convention 2026

Reuters
·
Jun 04

Longeveron shifts to capital-light model, targets licensing partners for laromestrocel

Reuters
·
May 21

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

THOMSON REUTERS
·
May 21

Longeveron Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $398.000K Beat $314.667K Estimate

Benzinga Earnings
·
May 14

Longeveron Q1 revenue rises, beats analyst estimates

Reuters
·
May 14

BRIEF-Longeveron Q1 EPS USD -0.19

Reuters
·
May 14

Longeveron Q1 Revenue USD 378 Thousand

THOMSON REUTERS
·
May 14

Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update

GlobeNewswire
·
May 14

Longeveron Q1 net loss narrows 6% to $4.74 million; revenue rises to $398,000

Reuters
·
May 14

Longeveron reports DMC approval for laromestrocel study to continue as designed

TIPRANKS
·
May 12

Longeveron Cut to Hold From Buy by Maxim Group

Dow Jones
·
May 12

Longeveron downgraded to Hold from Buy at Maxim

TIPRANKS
·
May 11